Mechanism of Action of Cytokinogenetic Therapy on Cancer Cells

Tumour necrosis factor (TNF-α) is an important endogenous cytokine protein that provides the body's natural defence against the occurrence of malignant tumours.
TNF-α promptly identifies pathological cells and starts the process of their destruction, acting together with cells of the immune system.
When the TNF 308 gene functions correctly, the body produces TNF-α (tumour necrosis factor), which stimulates the human immune system to fight cancer cells.
In cancer patients, the TNF 308 gene is often damaged or is poorly functioning, and as a result the immune cells cannot produce TNF-α in sufficient quantities to find and destroy cancer cells.
We have developed a personalized treatment that helps the body's natural defenders - an exogenous and recombinant TNF-Thymosin-α1.
Endogenous and exogenous TNF trigger the process of controlled destruction (apoptosis) of the cancer cell.
oncocareclinic...